查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2019241

心電圖設備市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Electrocardiogram (ECG) Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球心電圖（ECG）設備市場預計到 2025 年將達到 80 億美元，預計到 2035 年將以 4.4% 的複合年成長率成長至 122 億美元。

心電圖（ECG）設備市場-IMG1

全球心血管疾病發生率的上升正推動心電圖（ECG）市場穩定成長，從而持續刺激對精準心臟監測解決方案的需求。心電圖在追蹤心臟活動和輔助早期診斷方面發揮著至關重要的作用，其在強調預防醫學的現代醫療保健體系中的重要性日益凸顯。快速的技術進步，例如小型化、無線化和穿戴式解決方案的出現，使得在傳統臨床環境之外也能進行連續監測，這些都促進了市場的發展。與遠端醫療服務和數位健康平台的整合進一步推動了心電圖的應用，尤其是在居家照護領域。不斷上漲的醫療成本和日益增強的心臟健康意識正在推動定期篩檢和早期療育的普及。此外，人工智慧和數據分析技術的進步提高了診斷準確性，並提供了預測性見解，使心電圖系統對醫療專業人員而言更加可靠和高效。這些因素共同作用，持續鞏固了心電圖市場的長期成長動能。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 80億美元
預測金額 122億美元
複合年成長率 4.4%

有利於改善心臟疾病早期檢測和管理的醫療保健政策和舉措進一步推動了心電圖 (ECG) 設備市場的發展。醫療基礎設施投資的增加和診斷服務覆蓋範圍的擴大，為市場成長創造了新的機會。大眾對預防醫學和定期心臟檢查重要性的認知不斷提高，也促進了心電圖設備的普及。此外，將先進的軟體功能整合到心電圖系統中，提高了工作流程效率，並實現了醫療網路間的無縫資料共用，從而增強了心電圖設備在現代患者照護中的作用。

預計到2035年，診斷性心電圖（ECG）市場將以3.8%的複合年成長率成長，達到63億美元。該市場成長勢頭強勁，主要得益於醫療機構對準確及時的心臟評估需求不斷成長。診斷性心電圖在臨床實踐中仍然至關重要，因為它們能夠提供有關心臟活動的詳細信息，並有助於早期發現嚴重。人口老化和慢性病盛行率的上升進一步推動了該市場的成長。系統功能的不斷進步，例如增強的連接性和改進的分析能力，正使這些設備更有效率。

預計2035年，12導聯心電圖市場將以4.8%的複合年成長率成長，達到56億美元。該市場持續保持主導地位，主要得益於其能夠提供全面且高度精細的心臟評估。醫療專業人員依賴這些系統在評估複雜心臟疾病的準確性和可靠性。先進的數位化功能和便攜性的提升，提高了其在各種醫療環境中的可用性，推動了其普及應用，並進一步鞏固了其在臨床診斷中的重要性。

預計到2025年，美國心電圖（ECG）設備市場規模將達25億美元。該地區的成長主要得益於心血管疾病的高發生率以及對早期診斷和持續監測的高度重視。人口老化持續顯著推高市場需求，而攜帶式和穿戴式技術的進步則提高了設備的可及性。遠距遠端醫療解決方案的普及和心電圖系統的數位化整合進一步加速了其在醫療保健領域的應用。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性協議
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 心血管疾病盛行率增加
      • 心電圖設備的技術進步
      • 移動式和遙測式心電圖監視器的廣泛應用。
      • 人們對心臟健康的認知不斷提高
    • 產業潛在風險與挑戰
      • 先進心電圖設備高成本
      • 熟練專業人員短缺
    • 市場機遇
      • 遠端監測、遠端醫療和居家照護的擴展
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢（基於初步研究）
  • 穿戴式心電圖設備在陣發性心臟相關症狀患者的效用總結（基於初步調查）
  • 2025年價格分析（基於初步調查）
  • 人工智慧和生成式人工智慧對市場的影響
  • 客戶洞察（基於初步研究）
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品類型發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 診斷性心電圖設備
    • 靜態心電圖
    • 動態心電圖
  • 心電圖監測設備
    • 連續型心電圖監測
    • 心電遙測監測/心臟事件記錄器
    • 植入式心臟監測器
    • 其他心電圖監測設備

第6章 市場估算與預測：依鉛類型分類，2022-2035年

  • 單極型
  • 3 引腳型
  • 6 引腳型
  • 12 鉛式
  • 其他鉛類型

第7章 市場估計與預測：按性別分類的攜帶式設備市場，2022-2035年

  • 非攜帶式設備
  • 攜帶式

第8章 市場估算與預測：依最終用途分類，2022-2035年

  • 醫院和診所
  • 門診手術中心
  • 診斷中心
  • 居家照護設施
  • 其他最終用戶

第9章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • ALIVECOR
  • Allengers
  • biotricity
  • bionet
  • BIOTRONIK
  • Boston Scientific
  • BPL Medical Technologies
  • CARDIOLINE
  • FUKUDA
  • GE HealthCare
  • Baxter
  • PHILIPS
  • Medtronic
  • mindray
  • SPACELABS HEALTHCARE
簡介目錄
Product Code: 5425

The Global Electrocardiogram Devices Market was valued at USD 8 billion in 2025 and is estimated to grow at a CAGR of 4.4% to reach USD 12.2 billion by 2035.

Electrocardiogram (ECG) Devices Market - IMG1

The electrocardiogram devices market is experiencing consistent expansion as cardiovascular conditions continue to rise globally, creating a sustained need for accurate cardiac monitoring solutions. ECG devices play a vital role in tracking heart activity and supporting early diagnosis, which is increasingly critical in modern healthcare systems focused on preventive care. The market is also benefiting from rapid technological evolution, with the emergence of compact, wireless, and wearable solutions that allow continuous monitoring beyond traditional clinical environments. The growing integration of remote healthcare services and digital health platforms has further strengthened adoption, especially in home-based care settings. Increased healthcare spending and rising awareness around heart health are encouraging routine screenings and early intervention practices. In addition, advancements in artificial intelligence and data analytics are enhancing diagnostic precision and enabling predictive insights, making ECG systems more reliable and efficient for healthcare providers. These factors collectively continue to reinforce the long-term growth trajectory of the electrocardiogram devices market.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$8 Billion
Forecast Value$12.2 Billion
CAGR4.4%

The electrocardiogram devices market is further supported by favorable healthcare policies and initiatives aimed at improving early detection and management of cardiac conditions. Rising investments in healthcare infrastructure and expanding access to diagnostic services are creating new opportunities for market growth. Increasing public awareness regarding preventive healthcare and the importance of regular cardiac assessments is also contributing to higher adoption rates. Furthermore, the integration of advanced software capabilities within ECG systems is improving workflow efficiency and enabling seamless data sharing across healthcare networks, strengthening their role in modern patient care.

The diagnostic ECG machines segment is anticipated to grow at a CAGR of 3.8% and is expected to reach USD 6.3 billion by 2035. This segment is gaining momentum due to the growing need for accurate and timely cardiac evaluations across healthcare facilities. Diagnostic ECG machines remain essential in clinical environments as they provide detailed insights into heart activity, enabling early identification of serious conditions. The increasing aging population and the rising prevalence of chronic health issues are further contributing to segment growth. Continuous advancements in system capabilities, including enhanced connectivity and improved analytical features, are making these devices more efficient and user-friendly.

The 12-lead type segment is projected to grow at a CAGR of 4.8% and is expected to reach USD 5.6 billion by 2035. This segment continues to lead due to its ability to deliver comprehensive and highly detailed cardiac assessments. Healthcare professionals rely on these systems for their precision and reliability in evaluating complex heart conditions. The availability of advanced digital features and improved portability has increased their usability across various care settings, supporting their widespread adoption and reinforcing their importance in clinical diagnostics.

U.S. Electrocardiogram Devices Market reached USD 2.5 billion in 2025. Growth in the region is supported by a high burden of cardiovascular conditions and a strong focus on early diagnosis and continuous monitoring. The aging population continues to contribute significantly to demand, while advancements in portable and wearable technologies are improving accessibility. The widespread use of telehealth solutions and digital integration of ECG systems is further enhancing adoption across healthcare environments.

Key players operating in the Global Electrocardiogram Devices Market include ALIVECOR, Allengers, biotricity, bionet, BIOTRONIK, Boston Scientific, BPL Medical Technologies, CARDIOLINE, FUKUDA, GE HealthCare, Baxter, PHILIPS, Medtronic, Mindray, and SPACELABS HEALTHCARE. Companies in the electrocardiogram devices market are strengthening their competitive position through innovation, strategic partnerships, and expanded product portfolios. They are focusing on developing advanced portable and wearable ECG solutions integrated with AI-driven analytics to improve diagnostic accuracy and user convenience. Collaborations with healthcare providers and digital health platforms are enabling seamless data integration and remote monitoring capabilities. Businesses are also investing in research and development to enhance device performance, connectivity, and patient usability. Expanding distribution networks and entering emerging markets are helping companies increase their global footprint. Additionally, emphasis on regulatory compliance, quality assurance, and after-sales support is improving customer trust and long-term adoption.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Lead type trends
    • 2.2.4 Portability trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Technological advancements in ECG devices
      • 3.2.1.3 Increasing adoption of mobile and telemetry cardiac monitors
      • 3.2.1.4 Rising awareness about heart health
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced ECG devices
      • 3.2.2.2 Lack of skilled professionals
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of remote monitoring, telemedicine & home-based care
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by Primary Research)
  • 3.7 Overview on usefulness of wearable ECG devices in patients experiencing paroxysmal cardiac-related symptoms (Driven by Primary Research)
  • 3.8 Pricing analysis, 2025 (Driven by Primary Research)
  • 3.9 Impact of AI and generative AI on the market
  • 3.10 Customer insights (Driven by Primary Research)
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostic ECG machines
    • 5.2.1 Resting ECG
    • 5.2.2 Stress ECG
  • 5.3 Monitoring ECG devices
    • 5.3.1 Holter monitoring
    • 5.3.2 ECG telemetry monitoring/Event monitoring
    • 5.3.3 Implantable cardiac monitors
    • 5.3.4 Other monitoring ECG devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single lead type
  • 6.3 3 lead type
  • 6.4 6 lead type
  • 6.5 12 lead type
  • 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By Portability, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Non-portable device
  • 7.3 Portable device

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Diagnostic centers
  • 8.5 Home care settings
  • 8.6 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ALIVECOR
  • 10.2 Allengers
  • 10.3 biotricity
  • 10.4 bionet
  • 10.5 BIOTRONIK
  • 10.6 Boston Scientific
  • 10.7 BPL Medical Technologies
  • 10.8 CARDIOLINE
  • 10.9 FUKUDA
  • 10.10 GE HealthCare
  • 10.11 Baxter
  • 10.12 PHILIPS
  • 10.13 Medtronic
  • 10.14 mindray
  • 10.15 SPACELABS HEALTHCARE